Cargando…
Activation of G protein-coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade
Female sex and history of prior pregnancies are associated with favorable melanoma outcomes. Here, we show that much of the melanoma protective effect likely results from estrogen signaling through the G protein-coupled estrogen receptor (GPER) on melanocytes. Selective GPER activation in primary me...
Autores principales: | Natale, Christopher A, Li, Jinyang, Zhang, Junqian, Dahal, Ankit, Dentchev, Tzvete, Stanger, Ben Z, Ridky, Todd W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5770157/ https://www.ncbi.nlm.nih.gov/pubmed/29336307 http://dx.doi.org/10.7554/eLife.31770 |
Ejemplares similares
-
Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma
por: Natale, Christopher A., et al.
Publicado: (2020) -
Characterization of genetics in patients with mucosal melanoma treated with immune checkpoint blockade
por: Buchbinder, Elizabeth I., et al.
Publicado: (2021) -
The role of IFN-γ-signalling in response to immune checkpoint blockade therapy
por: Wong, Chun Wai, et al.
Publicado: (2023) -
T-cell response to checkpoint blockade immunotherapies: from fundamental mechanisms to treatment signatures
por: Elliot, Thomas A.E., et al.
Publicado: (2023) -
Isoprostane F(2α)-VI, a new marker of oxidative stress, increases following light damage to the mouse retina
por: Dentchev, Tzvete, et al.
Publicado: (2007)